DXN's investor relations keep shareholders informed about the company's progress and plans
Cyberjaya, 4 September 2025 – DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, today announced that its wholly-owned subsidiary, Daxen Middle East Food Manufacturing LLC (“Daxen Middle East”), has entered into a sale and purchase agreement (“SPA”) to acquire a residential apartment unit at Burj Khalifa, Dubai, United Arab Emirates, for a total cash consideration of AED6.4 million (approximately RM7.4 million) (the “Acquisition”).
The Acquisition, financed entirely through internally generated funds, represents less than 0.6% of DXN’s total net assets of RM1.3 billion, as at 28 February 2025 (“FY25”), with no material impact on balance sheet, and will not affect dividends, ongoing investments in research & development (“R&D”), or expansion plans. This Acquisition is complementary to, and does not divert resources from, DXN’s core priorities in R&D, manufacturing, and market expansion.
The property will serve as a member reward and training hub, complementing DXN’s existing facilities in Penang and Cyberjaya, and will be used for leadership development, incentive programmes, and VIP events. It also offers potential rental income and capital appreciation.
As the transaction involved related parties, all interested directors abstained from deliberations and voting. The Audit Committee independently reviewed the terms, confirming they are fair and reasonable, and approval was granted solely by non-interested directors in line with Bursa Malaysia requirements.
Dubai is an increasingly important hub for DXN, with its manufacturing plant established in 2023 and the Middle East contributing over 10.0% of the Group’s revenue in FY25. This acquisition strengthens DXN’s long-term commitment to member engagement and growth in the region.
Health
Food and Beverage
Personal Care
Nutrition
Beauty
Branch
Business
Register